ArticleActa pharmaceutica Sinica. B2024

CRISPR-Cas9 gene editing strengthens cuproptosis/chemodynamic/ferroptosis synergistic cancer therapy.

Xiaoyu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.